Matti Laato - UTU Research Portal

Matti Laato

- Docent,
Faculty of Medicine (University of Turku)

Department of Urology

mlaato@utu.fi

Kiinamyllynkatu 10

Turku

Areas of expertise

wound healing; urologic cancer; urine tract infection

Biography

-Chairman of the Scientific Steering Committee of Auria Biobank

-Member of the Ethics Committee of the Hospital District of Southwest Finland 22.5.2013 - 2021

-MATINE: member of expert sub-committee (Medicine,
health and behavioural sciences)

-Member of the expert responsibility area (ERVA) of the Turku University Hospital research committee for grant applications

-Vice-Head of Institute of Clinical Medicine 1.1.2014-

Research

wound healing; urologic cancer; urine tract infection

Teaching

-Tutkintojen suunnittelutoimikunnan jäsen 1993-2017

-C7 -lukukausijohtaja 1993-2017

-4:en lukuvuoden lukuvuosijohtaja 1.8.2017-

-Ammatillisen jatkokoulutuksen toimikunta varsinainen jäsen 1.4.2014 - 31.3.2022

-Urologian erikoistumiskoulutuksen toinen vastaavista

Publications

2 of 8

Siittimen kasvaimet (2018) Kirurgia Laato Matti, Syvänen Kari, Boström Peter
(D2 Article in a professional compilation book)
Siittimen tulehdukset (2018) Kirurgia Laato Matti, Syvänen Kari, Boström Peter
(D2 Article in a professional compilation book)
Torsio testis (2018) Kirurgia Laato Matti, Syvänen Kari, Boström Peter
(D2 Article in a professional compilation book)
Uretriitti (2018) Kirurgia Laato Matti, Syvänen Kari, Boström Peter
(D2 Article in a professional compilation book)
Varikoseele (2018) Kirurgia Laato Matti, Syvänen Kari, Boström Peter
(D2 Article in a professional compilation book)
Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy. (2016)
- Bladder Cancer
Boström PJ, Mirtti T, van Rhijn B, Fleshner NE, Finelli A, Laato M, Jewett MA, Moore MJ, Sridhar S, Nurmi M, Tannock IF, Zlotta AR.
(A1 Refereed original research article in a scientific journal)
Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy (2016)
- Bladder Cancer
Boström PJ, Thoms J, Sykes J, Ahmed O, Evans A, van Rhijn BW, Mirtti T, Stakhovskyi O, Laato M, Margel D, Pintilie M, Kuk C, Milosevic M, Zlotta AR, Bristow RG
(A1 Refereed original research article in a scientific journal)
Eturauhassyöpä – Käypä hoito -suositus (2014)
- Duodecim
Sirpa Aaltomaa, Pekka Jousilahti, Vesa Kataja, Merja Korpela, Paula Kujala, Matti Laato, Paula Lindholm, Mika Matikainen, Antti Rannikko, Raija Sipilä, Teuvo Tammela
(D1 Article in a professional journal)
Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer (2014)
- European Medical Journal Urology
Syvänen K, Järveläinen H, Taimen P, Laato M, Boström PJ
(A1 Refereed original research article in a scientific journal)
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy (2014)
- Urologic Oncology: Seminars and Original Investigations
Seikkula H, Syvänen K, Kurki S, Mirtti T, Taimen P, Laato M, Boström P
(A1 Refereed original research article in a scientific journal)